Literature DB >> 984037

The effect of thrombin on the uptake and transformation of arachidonic acid by human platelets.

F A Russell, D Deykin.   

Abstract

Washed human platelets take up arachidonic acid from plasma and incorporate the fatty acid into the major classes of complex lipids. Thrombin impairs net incorporation. It activates endogenous phospholipases which liberate arachidonic acid from phospholipids. As a consequence of thrombin induced aggregation platelets release arachidonic acid intermediates formed by the action of platelet fatty acid cyclooxygenase and by platelet fatty acid lipoxygenase. Cyclooxygenase, but not lipoxygenase, is inhibited by aspirin and indomethicin. Analysis of the pathways of arachidonic acid metabolism may furnish new insight into platelet function and into disorders of primary hemostasis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 984037     DOI: 10.1002/ajh.2830010107

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  6 in total

1.  The mobilization of arachidonic acid in platelets exposed to thrombin or ionophore A23187. Effects of adenosine triphosphate deprivation.

Authors:  S Rittenhouse-Simmons; D Deykin
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

Review 2.  The prostanoids in hemostasis and thrombosis: a review.

Authors:  J B Smith
Journal:  Am J Pathol       Date:  1980-06       Impact factor: 4.307

3.  Production of diglyceride from phosphatidylinositol in activated human platelets.

Authors:  S Rittenhouse-Simmons
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

4.  Increased arachidonic acid incorporation into platelet phospholipids in type 2 (non-insulin-dependent) diabetes.

Authors:  R Takahashi; I Morita; Y Saito; H Ito; S Murota
Journal:  Diabetologia       Date:  1984-02       Impact factor: 10.122

5.  Diglyceride lipase: a pathway for arachidonate release from human platelets.

Authors:  R L Bell; D A Kennerly; N Stanford; P W Majerus
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

6.  Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.

Authors:  M Minkes; N Stanford; M M Chi; G J Roth; A Raz; P Needleman; P W Majerus
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.